Study shows Covid-19 patients who took heartburn drug were less likely to die, but researchers urge caution

Patients who took a common heartburn medicine while hospitalized for Covid-19 were more than twice as likely to survive the infection, according to a paper posted Friday on a pre-publication website. But it's unclear whether the patients fared better because of the famotidine or if it was a coincidence.

from CNN.com - RSS Channel - App International Edition https://www.cnn.com/2020/05/09/health/famotidine-covid-19-correlation-study/index.html
via IFTTT